Keywords: astrazeneca, submits, snda, fda, casodex, filed, supplemental

AstraZeneca submits sNDA to FDA for Casodex

Article | 07 January 2002

Print This

AstraZeneca has filed a supplemental New Drug Application with the USFood and Drug Administration for its oral, once-daily hormonal drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in